Resting-State Glucose Metabolism Level Is Associated with the Regional Pattern of Amyloid Pathology in Alzheimer's Disease

Figure 1

FDG and PIB-PET images of a representative normal elderly subject and an Alzheimer’s disease (AD) patient. (a) Positron emission tomography (PET) imaging of FDG in a normal 65-year-old man (left upper panel) and a 60-year-old woman with AD (right upper panel). (b) PET imaging of PIB in the same normal subject (left lower panel) and the same AD patient (right lower panel).